• In June 2026, IMU Biosciences announced a partnership with Waters Corporation to combine Waters Biosciences' advanced flow cytometry and single‑cell platforms with IMU's AI‑driven High Definition Immunology analytics to enable real‑time, large‑scale immune system profiling across research and clinical settings.
• This collaboration aims to help establish a universal standard for immune profiling by pairing Waters' hardware and reagents with IMU's machine‑learning platform and expanding IMU's extensive immune dataset.
• We’ll now explore how Waters’ integration of AI‑enabled immune profiling through IMU could influence its long‑term investment narrative and growth drivers.

Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.

Waters Investment Narrative Recap

To own Waters, you have to believe it can turn its expanded life sciences toolkit into profitable, more recurring revenue while managing the complex BD Biosciences and Diagnostic Solutions integration. The IMU Biosciences partnership reinforces Waters’ push into AI-enabled, higher value workflows, but it does not change the near term reality that the biggest catalyst is successful BD integration, and the key risk is that expected cost and revenue synergies fall short or arrive later than planned.

The IMU announcement sits alongside a busy 2026 product and platform rollout, but the most relevant update is Waters’ Q1 2026 earnings, which showed strong revenue of US$1,267 million but a swing to a net loss of US$72 million, partly reflecting one off items. Against that backdrop, investors may view the IMU collaboration as an early signal of how Waters intends to push deeper into AI enabled, clinically relevant workflows that could support the longer term case if execution improves.

Yet even as Waters leans into AI enabled immune profiling, investors should be aware that its heavy reliance on aging core technologies could...

Waters’ narrative projects $7.5 billion revenue and $1.4 billion earnings by 2029.

Uncover how Waters' forecasts yield a $393.14 fair value, a 4% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts already expected Waters’ earnings to reach about US$1.4 billion by 2029, so this AI powered IMU tie up could either reinforce that bullish view or challenge it if concerns about aging core technologies and digital gaps prove more accurate than those upbeat forecasts.

Explore 3 other fair value estimates on Waters - why the stock might be worth just $393.14!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Waters research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Waters research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Waters' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Capitalize on the AI infrastructure supercycle with our selection of the 50 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Explore 30 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.